| Literature DB >> 25343993 |
Hannah M Kaneb1, Andrew W Folkmann2, Véronique V Belzil3, Li-En Jao2, Claire S Leblond4, Simon L Girard5, Hussein Daoud6, Anne Noreau7, Daniel Rochefort8, Pascale Hince8, Anna Szuto9, Annie Levert8, Sabrina Vidal10, Catherine André-Guimont11, William Camu12, Jean-Pierre Bouchard13, Nicolas Dupré13, Guy A Rouleau14, Susan R Wente2, Patrick A Dion15.
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the selective death of motor neurons. Causative mutations in the global RNA-processing proteins TDP-43 and FUS among others, as well as their aggregation in ALS patients, have identified defects in RNA metabolism as an important feature in this disease. Lethal congenital contracture syndrome 1 and lethal arthrogryposis with anterior horn cell disease are autosomal recessive fetal motor neuron diseases that are caused by mutations in another global RNA-processing protein, hGle1. In this study, we carried out the first screening of GLE1 in ALS patients (173 familial and 760 sporadic) and identified 2 deleterious mutations (1 splice site and 1 nonsense mutation) and 1 missense mutation. Functional analysis of the deleterious mutants revealed them to be unable to rescue motor neuron pathology in zebrafish morphants lacking Gle1. Furthermore, in HeLa cells, both mutations caused a depletion of hGle1 at the nuclear pore where it carries out an essential role in nuclear export of mRNA. These results suggest a haploinsufficiency mechanism and point to a causative role for GLE1 mutations in ALS patients. This further supports the involvement of global defects in RNA metabolism in ALS.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25343993 PMCID: PMC4321443 DOI: 10.1093/hmg/ddu545
Source DB: PubMed Journal: Hum Mol Genet ISSN: 0964-6906 Impact factor: 6.150